Sepsis Diagnostics Market Competitive Developments, M&A, Product Launch, R&D Analysis | Forecast – 2022
Sepsis, also known as blood poisoning, is recognized by low blood pressure, increased respiratory rate, and altered mental status. Tests used for checking red and white blood cells count can be used in rapid diagnosis of sepsis. The global sepsis diagnostics market report by Market Research Future (MRFR) outlines numerous drivers, challenges, trends, and opportunities pertinent for users to succeed in the forecast period of 2016 to 2022.
Sepsis Diagnostics Market Overview
The global market for sepsis diagnostics is expected to reach USD 710 million by 2022. It is expected to grow at a CAGR of 8% during the forecast period. High prevalence of sepsis is the major driver of the market. Two types of sepsis include the one which causes organ failure and the other is septic shock. According to the Center for Disease Control & Prevention (CDC), more than 1.7 million have been diagnosed with the disease in the U.S. The probability of acquiring sepsis from hospital-acquired infections (HAIs) can warrant the need for early diagnosis of the disease at an early stage.
Development of technologically advanced tests and approval of kits to curb the high prevalence can augur favorably for the market. For instance, T2 Systems was approved of a sepsis diagnosis test in 2018 for detection of bacterial pathogens in human blood. Awareness campaigns for the public may positively influence the global sepsis diagnostics market in the coming years.
Get Free Sample with Complete ToC, Including the Covid-19 Impact Analysis @ https://www.marketresearchfuture.com/sample_request/2110
Sepsis Diagnostics Market Segmentation
The global sepsis diagnostics market has been segmented by technology, product types, and end users.
By technology, the market covers molecular diagnostics, biomarkers, immunoassays and others. Different product types in the global sepsis diagnostics market entail kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.
Sepsis Diagnostics Market Regional Analysis
On the basis of the region, the global market is classified into North America, Europe, Asia Pacific (APAC), and the Middle East & Africa.
North America is expected to dominate the market and touch a valuation of USD 320 million by 2023. Prominent players in the region and favorable reimbursement policies are major drivers of the market. The excellent healthcare infrastructure and well-structured framework can positively drive sepsis diagnosis at these facilities. High frequency of product approvals and large number of cases of HAIs will induce massive demand in the global sepsis diagnostics market.
Europe has assumed the second position in the market after Americas and is predicted to exhibit 6.8% CAGR during the forecast period. Developments of rapid tests are the major driver of the regional market. For instance, the University of Strathclyde has developed a sepsis diagnosis test which can use a microelectrode to analyze the blood sample of the patient and provide results in 2 and half minutes.
On the other hand, APAC may register the fastest growth rate during the assessment period. Awareness of sepsis diagnostic tests and treatments in China and India can augur favorably for the market. Development of new kits and product launches can detect sepsis and ensure rapid patient recovery.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110
Sepsis Diagnostics Market Competition Outlook
T2 Biosystems, Inc., Cube Dx GmbH, Becton, Dickinson and Company, bioMérieux, Inc., Axis-Shield Diagnostics Ltd., Immunexpress, EKF Diagnostics, and Sandstone Diagnostics, Inc. are key players of the global sepsis diagnostics market.
Sepsis Diagnostics Industry News
Scientists at German Fraunhofer IGBI have developed a test for sepsis diagnosis within a few hours of extracting blood. The technique has a base in nanopore sequencing of microbial DNA.
Magnolia Medical has decided to partner with hospitals in the state of Seattle to provide doctors and staff with training for detection of false positive of sepsis among the pandemic of COVID-19.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Esophageal Cancer Market, Competitive landscape, Key Developments, & Growth Strategies
According to MRFR Analysis – Esophageal Cancer Market is growing at a CAGR of 8.7% during the forecast period 2017 To 2023. The Global Esophageal Cancer Market Industry Categorizes by Type, Phases, Treatment, And Region.
Esophageal Cancer Market Synopsis:
Cancer is one of the leading causes of death worldwide and is expected to witness the expansion of patient population in the years to come. One of the types of cancer that affect the food pipe connecting the mouth and stomach is the esophageal cancer which is majorly prevalent among the older adults belonging to 55 years and above age group. Market Research Future (MRFR) has found out that the global esophageal cancer market is projected to grow at a compound annual rate of 8.7% during the forecast period 2017 to 2023. It is underlined in the report that the market is anticipated to scale a decent valuation of USD 1000.1 Mn towards the close of 2023.
The rising burden of cancer has paved the way for innovation in the market. It is one of the prime areas of research in the medical field. With the increasing number of drug patent applications in conjunction with the rising count of clinical trials, the esophageal cancer market is expected to witness a boom over the next couple of years. Key players are anticipated to exponentially invest in the development of more effective treatments which is forecasted to aid the proliferation of the esophageal market in the foreseeable future.
Addiction to tobacco, betel nuts, etc. is the key factor responsible for triggering esophageal cancer. Increasing shift towards a sedentary lifestyle has led to an increase in addiction problems among the masses. This, in turn, is expected to catalyze the growth of patient population. The future trajectory of the esophageal market is likely to remain highly lucrative over the next couple of years.
People are getting increasingly aware of the availability of treatments which is poised to aid market expansion. The support extended by governments in conjunction with the early detection of the disease has unleashed massive opportunities for the market players. It is anticipated to augment the esophageal cancer market in the long run.
Get a FREE Sample with Complete TOC By considering the COVID-19 impact on market @ https://www.marketresearchfuture.com/sample_request/3280
Esophageal Cancer Market Segmentation:
By type, the global esophageal cancer market has been segmented into esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others.
On the basis of phase, the esophageal cancer market has been segmented into phase I, phases II, and phases III.
The esophageal cancer market by treatment, has been segmented into surgery, chemotherapy and radiotherapy and other.
Esophageal Cancer Market Regional Analysis:
The comprehensive geographical study of the global esophageal market spans across North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America is highly affected by the addiction of tobacco and other drugs which is expected to support the growth of the patient population. It is anticipated to catalyze the growth of the esophageal cancer market in the region. In addition, the support provided by the government for research & development of effective drugs is expected to propel market expansion over the next couple of years.
Europe is anticipated to maintain its prominence at the second spot through the assessment period. The region is poised to exhibit a rise in research & development. It is likely to favor growth of the regional esophageal market. In addition, Asia Pacific signifies developmental opportunities owing to the presence of a huge patient population.
Obtain Premium Research Report Details inclusive of COVID-19 Impact Analysis @ https://www.marketresearchfuture.com/reports/esophageal-cancer-market-3280
Esophageal Cancer Market Competitive Dashboard:
The share analysis of the esophageal market offered in this MRFR report studies key players such as Amgen Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim GmbH (Germany), GlaxoSmithKline Plc. (U.K), Johnson & Johnson (U.S.), Novartis AG (Switzerland), Gilead Sciences, Inc. (U.S.), and Merck & Co., Inc. (U.S.).
Esophageal Cancer Market Industry News:
In January 2019, Nivolumab, a medicine used for treating cancer, has extended OS in esophageal cancer of advanced stage as an outcome of the phase 3 of a clinical trial.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Oncology Information Systems Market, Major Players | Competitive Benchmarking, and Growth Strategies
Industry Research Report – Oncology Information Systems Market forecast till 2023, is latest research report published by MRFR. The Global Oncology Information Systems Market is segmented on the basis of Product & Service Type, Application, End User, and Region.
Oncology Information Systems Market Analysis
The global oncology information systems market is likely to grow at a 7.5% CAGR between 2018 to 2023, reveals the new Market Research Future (MRFR) report. The oncology information system, simply put, is a complete information & image management solution that helps to manage patient treatment schedules, treatment summaries, treatment delivery, and treatment plans. Owing to its excellent features and multiple benefits, the oncology information systems find wide applications in surgical oncology, radiation oncology, and medical oncology, among others.
Numerous factors are adding to the oncology information systems market demand. Such factors, as revealed by the latest MRFR report, include technological advances in these systems, rising investments in cancer research, increasing incidence of cancer, and growing geriatric population worldwide.
Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Oncology Information Systems Market @ https://www.marketresearchfuture.com/sample_request/7080
On the contrary, higher costs of oncology information systems may limit the oncology information systems market growth over the forecast period.
Oncology Information Systems Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the oncology information systems market based on end user, application, and product & service type.
By product & service type, the oncology information systems market is segmented into professional and software services. The software segment is again segmented into treatment planning systems and patient information systems. Professional services are again segmented into post-sale and maintenance services, implementation services, and consulting/optimization services. Of these, software services will lead the market over the forecast period.
By application, the oncology information systems market is segmented into surgical oncology, radiation oncology, and medical oncology. Of these, medical oncology will dominate the market over the forecast period.
By end user, the oncology information systems market is segmented into research centers, government institutes, hospitals and oncology clinics, and others. Of these, hospitals and oncology clinics will have a major share in the market over the forecast period.
Oncology Information Systems Market Regional Analysis
By region, the global oncology information systems market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will lead the market over the forecast period for the higher adoption of services or devices that are technologically advanced, presence of well-established healthcare infrastructure, rising prevalence of cancer, and presence of top market participants in the region.
The oncology information systems market in Europe is predicted to have favorable growth over the forecast period for increasing prevalence of cancer coupled with growing adoption and usage of healthcare IT in Italy, Spain, France, Germany, and the UK.
The oncology information systems market in the APAC region is predicted to grow at a high CAGR over the forecast period. Factors adding to the growth of the oncology information systems market in the region include the growing awareness about these systems in Australia, Japan, China, and India, the rising prevalence of cancer, and the presence of geriatric population base.
The oncology information systems market in the MEA will have a small share over the forecast period. The Middle East is predicted to have a major share in the market for improving quality healthcare. The healthcare sector in the region is constantly changing, and the rapidly developing technological landscape is likely to shape the healthcare sector in the upcoming years.
Oncology Information Systems Market Key Players
Key players profiled in the global oncology information systems market report include CureMD Healthcare, Bogardus Medical Systems, Inc., Epic Systems Corporation, RaySearch Laboratories, Flatiron Health, Inc., Varian Medical Systems, Inc., Varian Medical Systems, Inc., Altos Solutions, Inc., Elekta AB, McKesson Corporation, Cerner Corporation, Philips Healthcare, and Accuray Incorporated.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/oncology-information-systems-market-7080
Oncology Information Systems Market Industry News
March 2020: Sanofi has finally received the first FDA nod for its myeloma medicine, Sarclisa, in a decade for a wholly-owned oncology medicine.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Covid- 19 Impact on Surgical Equipment Market | Global Forecast – 2023
Industry Research Report – Surgical Equipment Market forecast till 2023, is latest research report on published by MRFR. The Global Surgical Equipment Market is segmented on the basis of Product Type, Application, End User, and Region.
Surgical Equipment Market Analysis
The global surgical equipment market is predicted to grow at a 6.2% CAGR between 2018- 2023, as per the recent report by Market Research Future (MRFR). Surgical equipment is used both for major and minor surgical procedures in surgical centers and hospitals. Monitoring devices, electrosurgical generators, electrosurgical devices, handheld instruments, surgical sutures and staplers, and others are the different types of surgical equipment.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/556
Various factors are adding to the surgical equipment market growth. According to the new MRFR report, such factors include favorable initiatives by the government, a growing number of surgical centers, a growing medical device market, rising geriatric population, and a growing number of surgeries in hospitals & ambulatory surgical centers. Besides, the rising prevalence of chronic diseases like skin diseases, obesity, and cardiovascular diseases are also adding market growth.
On the contrary, stringent regulatory policies for different regulatory authorities and high surgical device costs are factors that may limit the global surgical equipment market growth.
Surgical Equipment Market Segmentation
The MRFR report offers an inclusive segmental analysis of the global surgical equipment market report based on end user, application, and type.
By product type, the surgical equipment market is segmented into monitoring devices, electrosurgical generators, electrosurgical devices, handheld instruments, surgical sutures and staplers, and others. Surgical sutures & staplers are again segmented into non-absorbable and absorbable. Handheld instruments are again segmented into visual scope, sutures, forceps, and others. Electrosurgical devices are again categorized into electrosurgical instruments like electrosurgical generators, smoke evacuation system, electrosurgical pencils, HET bipolar systems, and others.
By application, the surgical equipment market is segmented into orthopedic surgery, cardiovascular surgeries, urology, wound closure, neurosurgery, and others.
By end user, the surgical equipment market is segmented into ambulatory surgical centers, hospitals, and others.
Surgical Equipment Market Regional Analysis
Based on the region, the global surgical equipment market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), and Middle East Africa (MEA). Of these, the Americas will have lions share in the market over the forecast period. Availability of surgical devices that are technologically advanced, the growing emphasis on quality care, booming medical sector, and the presence of key players are adding to the growth of the market in the region.
The global surgical equipment market in Europe is predicted to hold the second-largest share over the forecast period. Increasing healthcare spending, rise in outpatient surgeries, growing government support, and a growing number of industry players making surgical equipment are adding to the growth of the market in the region. France, the UK, and Germany are the major contributors in the region.
The global surgical equipment market in the APAC region is predicted to grow at a fast pace over the forecast period. The growing prevalence of chronic diseases, especially cardiovascular disease, growing awareness about quality care in surgical centers & hospitals, and burgeoning demand for surgical instruments and devices, are adding to the growth of the market in the region. Australia and India are the major contributors in the region for the growing healthcare expenditure and the availability of skilled and qualified medical experts.
The global surgical equipment market in the MEA is predicted to have sound growth over the forecast period. Demand for primary care services and rising availability of specialty services in Saudi Arabia and the UAE are adding to the growth of the market in the region.
Surgical Equipment Market Key Players
Leading players profiled in the global surgical equipment market report include Teleflex Incorporated (U.S.), Cook Medical (U.S.), Karl Storz GmbH & Co. Kg (Germany), Olympus Corporation (Japan), Abbott Laboratories (U.S.), KLS Martin Group (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Zimmer Holdings Inc. (U.S.), Smith & Nephew Plc (U.K), Alcon Laboratories Inc. (U.S.), Conmed Corporation (U.S.), Johnsons & Johnsons (U.S.), Stryker Corporation (U.S.), and Medtronic Plc. (U.S.).
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/surgical-equipment-market-556
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Transthyretin Amyloidosis Market Size is likely to Register Sturdy Growth During the Forecast Period (2018- 2023)
Transthyretin (TTR) Amyloidosis Market Research Report - Global Forecast till 2023, Published by Market Research Future. MRFR Provides Transthyretin (TTR) Amyloidosis Industry Updates, Size, Share, Growth, Competitive Landscape, Regional Outlook.
Transthyretin (TTR) Amyloidosis Market Overview
The Transthyretin (TTR) amyloidosis market is likely to register a robust growth over the forecast period. Transthyretin (TTR) amyloidosis is a health condition characterized by anomalous deposits of a protein named amyloid (amyloidosis) in a person's tissues and organs. It usually affects autonomic neuropathy or peripheral neuropathic system and cardiac system. Amyloidosis symptoms are often ambiguous having similarity to symptoms caused by other conditions. The symptoms vary based on the location and type of the amyloid deposits. Primarily, three major types of transthyretin amyloidosis have been identified. The neuropathic type of transthyretin amyloidosis affects the autonomic and peripheral nervous systems, resulting in trouble controlling bodily functions and peripheral neuropathy. The leptomeningeal type of transthyretin amyloidosis mostly affects the central nervous system. The cardiac type of Transthyretin (TTR) amyloidosis puts patients at the risk of orthostatic hypertension, cardiomegaly, and arrhythmia.
Get a FREE Sample with Complete TOC By considering the COVID-19 impact on market @ https://www.marketresearchfuture.com/sample_request/6155
The surging African American population, increasing number of ATTR therapeutic drug launches, increasing average income of individuals, and growing healthcare awareness among people serves as key factors for driving the Transthyretin (TTR) amyloidosis market growth.
However, progress of the market can be restricted by strict governing policies, incorrect diagnosis of TTR ailments, restraints on clinical trials, and high cost of TTR drugs. Unavailability of advanced diagnostic methods in the middle-income nations and lack of knowledge about Transthyretin amyloidosis acts as major challenges to the market.
Transthyretin (TTR) Amyloidosis Market Segmentation
The worldwide Transthyretin (TTR) amyloidosis market has been segmented based on treatment, gender, end-user, and disease type. Based on treatment, the market has been segmented into organ transplantation, RNAi therapy, small molecules treatment, and others. Small molecules treatment has been sub-segmented as diflunisal and tafamidis. Based on gender, the market has been segmented into male and female. Based on end-user, the market has been segmented into ambulatory surgical centers, hospitals and clinics, and others. Based on disease type, the market has been segmented into Transthyretin (TTR) familial amyloid polyneuropathy, Transthyretin (TTR) familial amyloid cardiomyopathy, and others.
Transthyretin (TTR) Amyloidosis Market Regional Analysis
The Americas hold the largest market share for Transthyretin (TTR) amyloidosis. The growth is owing to the rising occurrence of amyloidosis among adults and older population and increasing elderly population. For instance, a report published by ASCO Journal in 2016 stated that almost 4,000 people suffered from amyloidosis each year in the United States. Additionally, increasing government funding, technologically advanced diagnostic equipment, and surging research initiatives in advanced medical treatment options are likely to drive the market. The existence of leading pharmaceutical brands such as Merck and Pfizer also boost the market in this region.
Europe represents the second largest share in the global Transthyretin (TTR) amyloidosis market. The Europe market has been anticipated to grow remarkably over the forecast period. The growth is owing to soaring healthcare expenditure, availability of progressive treatment facilities, amplifying demand for improved healthcare infrastructure collectively with government initiatives for healthcare reform. In the U.K., almost 60 new cases of Transthyretin (TTR) amyloidosis are reported every year. Furthermore, increased affordability coupled with well-established medical device manufacturers accelerate the market to a great extent. However, increasing incidences of wrong diagnosis and the inefficiency of treatment procedures are likely to restrict the growth in the Europe market.
Asia Pacific market has been fast expanding owing to rising aged population. Moreover, increasing patient pool, government initiatives to enhance the healthcare facility, availability of favorable insurance reimbursement policies, and a rapid adoption of advanced technology are likely to stimulate the Transthyretin (TTR) amyloidosis market.
The Middle East and Africa market has been anticipated to register least growth owing to limited access to treatment facilities and lack of health awareness. In the Middle East, Saudi Arabia and the United Arab Emirates are the largest markets. The market growth has been attributed to the easy accessibility of specialty care centers and growth of healthcare industry. However, the market is expected to witness steady development due to the genetical predisposition of Africans for transthyretin amyloidosis and administrative initiatives to excel the quality of healthcare in the region.
Transthyretin (TTR) Amyloidosis Market Key Players
The global Transthyretin (TTR) amyloidosis market has been dominated by key players such as Pfizer, Alnylam Pharmaceuticals, Ionis Pharmaceuticals Inc., Arcturus Therapeutics, Corino Therapeutics Inc, and Proclara Bioscience.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/transthyretin-amyloidosis-market-6155
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
)